Avid Bioservices, Inc. (CDMO)

Avid Bioservices Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Net Income	-152.05	-140.75	0.26	127.67	11.21	-10.47
Depreciation & Amortization	12.47	11.11	7.21	4.48	3.45	3.09
Other Amortization	1.45	1.5	1.05	1.03	0.92	-
Loss (Gain) From Sale of Assets	0.18	0.23	0.14	0.38	-	0.01
Stock-Based Compensation	11.06	9.73	10.98	7.38	3.85	2.5
Other Operating Activities	118.7	115.69	1.33	-115.08	-	-
Change in Accounts Receivable	-5.99	-1.1	-1.99	-0.96	-13.05	-0.21
Change in Inventory	10.51	13.53	-17.85	-14.19	-0.99	-4.33
Change in Accounts Payable	-6.58	7.13	0.96	-0.94	-0.61	0.8
Change in Unearned Revenue	5.51	2.54	-16.45	3.03	21.65	14.47
Change in Other Net Operating Assets	10	-8.65	1.63	-3.33	4.74	-0.05
Operating Cash Flow	5.26	10.95	-12.72	9.47	31.18	5.83
Operating Cash Flow Growth	137.70%	-	-	-69.65%	435.13%	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Capital Expenditures	-14.94	-31.81	-77.8	-56.41	-9.86	-3.81
Investing Cash Flow	-14.94	-31.81	-77.8	-56.41	-9.86	-3.81

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Short-Term Debt Issued	-	-	-	-	-	4.38
Long-Term Debt Issued	-	163.04	-	-	138.46	-
Total Debt Issued	155.63	163.04	-	-	138.46	4.38
Short-Term Debt Repaid	-	-	-	-	-4.38	-
Long-Term Debt Repaid	-	-144.37	-0.51	-0.16	-12.93	-0.08
Total Debt Repaid	-145.08	-144.37	-0.51	-0.16	-17.31	-0.08
Net Debt Issued (Repaid)	10.55	18.67	-0.51	-0.16	121.16	4.3
Issuance of Common Stock	1.12	1.4	3.41	3.36	38.48	1.12
Preferred Dividends Paid	-	-	-	-	-4.46	-4.33
Dividends Paid	-	-	-	-	-4.46	-4.33
Other Financing Activities	-	-	-	-	-5.8	-
Financing Cash Flow	11.67	20.07	2.9	3.2	112.34	1.1

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Net Cash Flow	1.99	-0.79	-87.62	-43.75	133.65	3.11

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Free Cash Flow	-9.68	-20.85	-90.53	-46.95	21.32	2.02
Free Cash Flow Growth	-	-	-	-	957.97%	-
Free Cash Flow Margin	-6.43%	-14.90%	-60.65%	-39.25%	22.24%	3.38%
Free Cash Flow Per Share	-0.15	-0.33	-1.42	-0.67	0.36	0.04
Levered Free Cash Flow	-1.08	-16.31	-77.84	-48.82	21.6	6.33
Unlevered Free Cash Flow	3	-15.1	-77.01	-48.17	21.41	6.34

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash Interest Paid	6.42	2.56	1.12	1.67	0.01	0.01
Cash Income Tax Paid	0.03	0.02	0.26	0.06	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error